Table 1 Main characteristics of 207 patients with locoregional breast cancer
Characteristics | N | % | |
|---|---|---|---|
Total | 207 | 100 | |
Age (range) | 56 | (30-88) | |
Tumor size | |||
T1 | 121 | 58,50% | |
T2 | 76 | 36,70% | |
T3-T4 | 10 | 4,80% | |
Lymph node | |||
Negative | 106 | 51,20% | |
Positive | 101 | 48,80% | |
Histology | |||
Ductal | 173 | 83,60% | |
Lobular | 24 | 11,60% | |
Other | 10 | 4,80% | |
Tumor grade (Scarff-Bloom-Richardson) | |||
1 | 52 | 25,10% | |
2 | 96 | 46,40% | |
3 | 59 | 28,50% | |
Estrogen receptor | |||
Negative | 53 | 25,60% | |
Positive | 153 | 73,90% | |
Progesterone receptor | |||
Negative | 61 | 29,50% | |
Positive | 145 | 70,00% | |
Her2-neu expression (IHC) | |||
0, 1+ or 2+ | 182 | 87,90% | |
3+ | 22 | 10,60% | |
Unknown | 3 | 1,40% | |
CCR6 expression on Tumor cells | |||
Negative | 130 | 64,4% | |
Positive | 72 | 35,6% | |
CCR7 expression on Stromal cells | |||
Negative | 118 | 57,0% | |
Positive | 89 | 43,0% | |
CCL19 expression on Tumor cells | |||
Negative | 95 | 46,6% | |
Positive | 109 | 53,4% | |
CCL19 expression on Dendritic cells | |||
Negative | 103 | 50,5% | |
Positive | 101 | 49,5% | |